Volume 124, Issue 5 , Pages 903-910.e7, November 2009
Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age
Background
Clinicians have difficulty in diagnosing asthma in preschool children with suggestive symptoms.
Objective
We sought to develop a clinical asthma prediction score for preschool children who have asthma-like symptoms for the first time.
Methods
The Prevalence and Incidence of Asthma and Mite Allergy birth cohort followed 3,963 children for 8 years. Between 0 and 4 years of age, 2,171 (55%) children reported “wheezing,” “coughing at night without a cold,” or both. In these children possible predictor variables for asthma were assessed at the age respiratory symptoms were first reported. Asthma was defined as wheezing, inhaled steroid prescription, or a doctor's diagnosis of asthma at both age 7 and 8 years of age.
Results
Eleven percent of children with symptoms at 0 to 4 years of age had asthma at 7 to 8 years of age. Eight clinical parameters independently predicted asthma at 7 to 8 years of age: male sex, postterm delivery, parental education and inhaled medication, wheezing frequency, wheeze/dyspnea apart from colds, respiratory infections, and eczema. In 72% of the cases, the model accurately discriminated between asthmatic and nonasthmatic children. A clinical risk score was developed (range, 0-55 points). Symptomatic children with a score of less than 10 points had a 3% risk, whereas children with a score of 30 points or greater had a 42% risk of asthma.
Conclusion
A risk score based on 8 readily available clinical parameters at the time preschool children first reported asthma-like symptoms predicted the risk of asthma at 7 to 8 years of age.
Key words: Asthma, children, wheeze, cough, prognosis, prediction, longitudinal, birth cohort
Abbreviation used: PIAMA, Prevalence and Incidence of Asthma and Mite Allergy
Supported by the Netherlands Organisation for Health Research and Development; the Netherlands Organisation for Scientific Research; the Netherlands Asthma Fund; the Netherlands Ministry of Spatial Planning, Housing, and the Environment; and the Netherlands Ministry of Health, Welfare and Sport. The salary of D. C. was paid by a “Toptalent” grant from Netherlands Organisation for Scientific Research (NWO).
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(09)01011-2
doi:10.1016/j.jaci.2009.06.045
© 2009 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 124, Issue 5 , Pages 903-910.e7, November 2009
